AstraZeneca And Damages In 'At-Risk' Generic Drug Launches
An "at-risk" generic drug launch occurs when a company launches a generic pharmaceutical product into the marketplace while patent litigation is still ongoing. These situations can be highly complex from a...To view the full article, register now.
Already a subscriber? Click here to view full article